KPV
- Category
- Immune & Defense
- Administration routes
- Injectable
- Regulatory status
- Not FDA-approved
What it is
A tripeptide fragment of the hormone alpha-MSH, marketed for gut and skin inflammation and mucosal healing. Its anti-inflammatory mechanism (blocking the NF-kB pathway) is characterized in cell and animal models, and no human clinical trials or safety studies have been completed. The FDA has stated it lacks human exposure and safety data. Most supply is unregulated research-grade product of uncertain purity, and it is not an approved drug in the US.
Read Full recordStudied uses & evidence
Studied uses(7)
Intestinal anti-inflammatory activity
MediumMouse colitis models show reduced colonic inflammation and tissue damage.
NF-kB pathway inhibition
MediumBlocks NF-kB and MAPK inflammatory signaling at nanomolar concentrations in cell studies.
Pro-inflammatory cytokine reduction
MediumLowers IL-1beta, IL-6, TNF-alpha, and IFN-gamma while sparing anti-inflammatory IL-10.
Evidence limits
- Evidence Level
- Preclinical
100% of evidence is from cell culture and animal models. No human safety, pharmacokinetic, or efficacy data exists. FDA has stated it lacks human exposure data on KPV. Multiple rodent colitis models show consistent anti-inflammatory efficacy.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
Do not use if
Active infection requiring immune response
ModerateKPV's strong anti-inflammatory action via NF-kB suppression may impair immune defense during active infection.
Organ transplant recipients
ModerateImmune-modulating properties may interact with immunosuppressive regimens unpredictably.
General cautions
Pregnancy
AbsoluteNo reproductive safety data for this MSH-derived peptide.
Risk summary(6)
Risks = level of concern: High · Moderate · Low · Theoretical
Zero human clinical trials or safety studies completed
HighFDA has explicitly stated it lacks human exposure/safety data on KPV
HighTheoretical immunosuppression risk
TheoreticalContraindicated in pregnancy, breastfeeding, cancer history
LowResearch-grade products may have purity/contamination issues
ModerateLong-term effects unknown
Moderate
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.